第5章 イントロダクション

第6章 市場情勢

第7章 市場区分：応用別

第8章 心臓欠損閉鎖デバイスの規制認可

第9章 地域区分

第10章 主要国

第11章 購買基準

第12章 市場成長促進要因

第13章 促進要因とその影響

第14章 市場課題

第15章 促進要因と課題の影響

第16章 市場動向

第17章 動向とその影響

第18章 ベンダー情勢

競合シナリオ

ベンダー分析

その他の有力ベンダー

第19章 主要ベンダー分析

事業概要、主要情報、SWOT分析など

Boston Scientific Corp.

St. Jude Medical Inc.

W. L. Gore & Associates

第20章 関連レポート

図表

目次

Product Code: IRTNTR3913

About Heart Defect Closure Devices

Heart defect closure devices are used for the treatment of several CHDs. The
heart closure devices help when closing the ostium/ hole/ deficiency in the
structure of the heart present in the septal walls or blood vessels that
occurs in the patients with CHDs. CHD is an anomaly in the structure of the
heart present at the time of birth, which are among the most common types of
birth defects. Some of the CHDs include ASD, PFO, VSD, PDA and LAA. These
defects cause disruption of the normal flow of blood through the heart. CHDs
can happen because of incomplete or abnormal development of the heart of the
fetus in the womb during the very early weeks of pregnancy.

TechNavio's analysts forecast the Global Heart Defect Closure Devices market
will grow at a CAGR of 9 percent over the period 2013-2018.

Covered in this Report

The Global Heart Defect Closure Devices market can be categorized into
segments on the basis of heart defects: Atrial Septal Defect, Left Atrial
Appendage, Patent Foramen Ovale, Patent Ductus Arteriosus, and Ventricular
Septal Defect. TechNavio's report, the Global Heart Defect Closure Devices
Market 2014-2018, has been prepared based on an in-depth market analysis with
inputs from industry experts. The report covers the Americas, and the EMEA and
APAC regions; it also covers the Global Heart Defect Closure Devices market
landscape and its growth prospects in the coming years. The report also
includes a discussion of the key vendors operating in this market.

Key Regions

Americas

EMEA

APAC

Key Vendors

Boston Scientific Corp.

St. Jude Medical Inc.

W.L. Gore and Associates Inc.

Other Prominent Vendors

Biosense Webster

Cardia Inc.

LifeTech Scientific

Maquet Cardiovascular

Medtronic

Occlutech Holding AG

Pfm medical

Starway Medical Technology

Terumo Cardiovascular

Key Market Driver

Increase in Incidence of CHDs.

For a full, detailed list, view our report.

Key Market Challenge

Potential Risk of Complications.

For a full, detailed list, view our report.

Key Market Trend

Emerging Use of LAA Closure Devices for Stroke Prevention.

For a full, detailed list, view our report.

Key questions answered in this report:

What will the market size be in 2018 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?